NKX2-8 is a homeodomain-containing transcription factor belonging to the NK2 gene family that plays critical roles in development and cancer. During embryonic development, NKX2-8 is expressed in ventral foregut endoderm, myocardial mesoderm, and epithelium of branchial arches, suggesting roles in heart and foregut development 1. In the respiratory system, NKX2-8 localizes to tracheobronchial basal cells and functions as a regulator of progenitor cell populations, with knockout mice showing tracheobronchial hyperplasia and dysplasia due to deregulated stem cell proliferation 2. NKX2-8 predominantly functions as a tumor suppressor in multiple cancer types. In bladder cancer, reduced NKX2-8 expression correlates with advanced tumor classification and poor survival, with the protein inhibiting cell proliferation through G1/S phase arrest via upregulation of FOXO3a and inhibition of MEK/ERK signaling 3. Similar tumor suppressor functions are observed in hepatocellular carcinoma and esophageal squamous cell carcinoma, where NKX2-8 downregulation promotes angiogenesis through NF-κB activation 45. Additionally, NKX2-8 enhances chemosensitivity in bladder cancer by transcriptionally repressing MDR1 expression 6. Coactivation of TTF-1 and NKX2-8 pathways identifies high-risk lung cancer patients with poor prognosis and cisplatin resistance 7.